Cancer Therapy
The latest news about Cancer Therapy: headlines, AI summaries and the full story from every source.
- AnaptysBio and GSK Receive FDA Label Expansion for Jemperli in Rectal Cancer
- Tempus AI Expands Cancer Therapy Collaboration with Moderna and Merck
- Inhibrx's Experimental Cancer Therapy Outperforms Merck's Keytruda in Trial Data
- HutchMed Enters Licensing Deal with GSK for Cancer Therapy, Could Generate Up to $1.295 Billion
- Tempus AI's Acquisition of Personalis Gains Strategic Momentum Following Melanoma Trial Success
- Biotech Stocks Reach Post-Pandemic High Following Moderna's Trial Success
- Stanley Druckenmiller Invests in Revolution Medicines Amid Strong Clinical Results
- FDA Grants Priority Review for Johnson & Johnson's Expanded Use Application for Rybrevant Faspro
- Summit Therapeutics Shares Drop After Releasing Late-Stage Trial Data for Lung Cancer Drug
- Legend Biotech Shares Rise Sharply Following Positive Phase 1 Trial Results for New Cancer Therapy
- Gilead Sciences Announces New Cancer Therapy Data Presentations
- Akari Therapeutics Reports Positive Preclinical Data for Cancer Therapy
- ImmunityBio Acquires U.S. Rights to BCG Therapy from Japan BCG Laboratory
- Cullinan Therapeutics and Taiho Pharmaceutical Receive FDA Review for Cancer Therapy
- Promatix Biosciences Presents Data on Bispecific Discovery Platform at AACR 2026